| Financial Year |
March 31 2023 |
| Monetary Funds |
369,348,583.42 |
| Held-for-trading Financial Assets |
80,430,465.75 |
| Notes Receivable |
-- |
| Accounts Receivable |
392,868,018.00 |
| Advances to Suppliers |
15,624,645.15 |
| Other Receivables |
33,589,976.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
607,655,733.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
49,102,914.18 |
| Total Current Assets |
1,548,620,336.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
195,108,675.44 |
| Investment Properties |
907,062.23 |
| Fixed Assetes |
997,480,426.34 |
| Under-construction Projects |
233,197,735.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
94,558,911.57 |
| R&D expenses |
-- |
| Goodwill |
226,068,413.99 |
| Long-Term Deferred and Prepaid Expenses |
74,845,891.43 |
| Deferred Income Tax Assets |
83,839,241.22 |
| Other Non-Current Assets |
75,784,415.43 |
| Sub-Total of Non-Current Assets |
2,100,017,111.70 |
| Total Assets |
3,648,637,448.59 |
| Short-Term Loans |
230,032,063.88 |
| Trading Financial liabilities |
2,161,000.00 |
| Notes Payable |
-- |
| Accounts Payable |
266,985,403.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
79,204,487.73 |
| Taxes Payable |
13,733,003.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,203,675.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,554,162.77 |
| Other Current Liabilities |
12,978,068.09 |
| Sub-Total of Current Liabilities |
640,961,031.53 |
| Long-term Loans |
44,466,799.51 |
| Bonds Payable |
658,059,481.28 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,794,662.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
771,902,366.41 |
| Total Liabilities |
1,412,863,397.94 |
| Paid-In Capital(Or Share Stock) |
294,112,698.00 |
| Capital Surplus |
1,144,631,724.60 |
| Surplus Reserve |
43,930,548.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
569,902,703.53 |
| Minority Stockholder's Interest |
164,432,259.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,071,341,791.12 |
| Owner's Equity（Stockholder's Equity） |
2,235,774,050.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,648,637,448.59 |
